Bioceres Crop Solutions Stock-Based Compensation Growth & History (BIOX)
Bioceres Crop Solutions's stock-based compensation was $4.4M for fiscal 2025.
View full Bioceres Crop Solutions company overviewBioceres Crop Solutions annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | $4.4M | −$9.7M | −68.97% |
| 2024 | 2024-06-30 | $14.1M | $10.7M | +313.89% |
| 2023 | 2023-06-30 | $3.4M | $2.0M | +138.69% |
| 2022 | 2022-06-30 | $1.4M | −$224,390 | −13.56% |
| 2021 | 2021-06-30 | $1.7M | −$1.8M | −51.72% |
| 2020 | 2020-06-30 | $3.4M | −$17.5M | −83.59% |
| 2019 | 2019-06-30 | $20.9M | $20.9M | +69534.36% |
| 2018 | 2018-06-30 | $30,005 | — | — |
Bioceres Crop Solutions quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | −$533 | −$1.4M | — |
| Q1 2026 | 2025-09-30 | $533 | −$809,052 | −99.93% |
| Q4 2025 | 2025-06-30 | $1.0M | −$1.6M | −61.05% |
| Q3 2025 | 2025-03-31 | $1.1M | −$1.8M | −61.22% |
| Q2 2025 | 2024-12-31 | $1.4M | −$935,747 | −40.10% |
| Q1 2025 | 2024-09-30 | $809,585 | −$5.4M | −86.93% |
| Q4 2024 | 2024-06-30 | $2.7M | $1.9M | +261.08% |
| Q3 2024 | 2024-03-31 | $3.0M | $2.3M | +378.12% |
| Q2 2024 | 2023-12-31 | $2.3M | $498,552 | +27.17% |
| Q1 2024 | 2023-09-30 | $6.2M | $6.0M | +2624.28% |
| Q4 2023 | 2023-06-30 | $734,890 | — | — |
| Q3 2023 | 2023-03-31 | $617,873 | $357,747 | +137.53% |
| Q2 2023 | 2022-12-31 | $1.8M | — | — |
| Q1 2023 | 2022-09-30 | $227,351 | — | — |
| Q3 2022 | 2022-03-31 | $260,126 | — | — |
Bioceres Crop Solutions stock-based compensation trends
Over the last five fiscal years, Bioceres Crop Solutions's stock-based compensation increased from $3.4M to $4.4M, a change of $958,659. The latest reported quarter, Q2 2026, shows −$533.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioceres Crop Solutions source filings ↗